PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma

• Published in: Signal transduction and targeted therapy Vol. 6; no. 1; p. 86
• Main Authors: Wang, Ning, Tan, Hor-Yue, Lu, Yuanjun, Chan, Yau-Tuen, Wang, Di, Guo, Wei, Xu, Yu, Zhang, Cheng, Chen, Feiyu, Tang, Guoyi, Feng, Yibin
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 26.02.2021; Nature Publishing Group
• Subjects: 631/67/327; 692/4020/1503/1504; Argonaute Proteins - antagonists & inhibitors; Argonaute Proteins - genetics; Cancer Research; Carcinogenesis - genetics; Carcinogenesis - immunology; Carcinogenesis - metabolism; Carcinoma, Hepatocellular - genetics; Carcinoma, Hepatocellular - immunology; Carcinoma, Hepatocellular - metabolism; Carcinoma, Hepatocellular - pathology; Cell Biology; Cell Line, Tumor; Cell Proliferation - genetics; Complement C3 - genetics; Fatty acids; Fatty Acids - metabolism; Gene Expression Regulation, Neoplastic; Glycolysis - genetics; Humans; Immunity - immunology; Interleukin-10 - genetics; Interleukin-10 - immunology; Internal Medicine; Liver cancer; Liver Neoplasms - genetics; Liver Neoplasms - immunology; Liver Neoplasms - metabolism; Liver Neoplasms - pathology; Medicine; Medicine & Public Health; Metabolism; Myeloid-Derived Suppressor Cells - immunology; Myeloid-Derived Suppressor Cells - metabolism; Oncology; p38 Mitogen-Activated Protein Kinases - genetics; p38 Mitogen-Activated Protein Kinases - immunology; Pathology; RNA-Seq; Signal Transduction - genetics; Tumor Microenvironment - genetics; Tumors
• ISSN: 2059-3635; 2095-9907; 2059-3635
• DOI: 10.1038/s41392-021-00485-8

Altered energy metabolism of cancer cells shapes the immune cell response in the tumor microenvironment that facilitates tumor progression. Herein, we reported the novel of tumor cell-expressed Piwi Like RNA-Mediated Gene Silencing 1 (PIWIL1) in mediating the crosstalk of fatty acid metabolism and immune response of human hepatocellular carcinoma (HCC). PIWIL1 expression in HCC was increased compared to normal hepatic tissues and was positively correlated with the proliferation rate of HCC cell lines. PIWIL1 overexpression accelerated in vitro proliferation and in vivo growth of HCC tumors, while PIWIL1 knockdown showed opposite effects. PIWIL1 increased oxygen consumption and energy production via fatty acid metabolism without altering aerobic glycolysis. Inhibition of fatty acid metabolism abolished PIWIL1-induced HCC proliferation and growth. RNA-seq analysis revealed that immune system regulation might be involved, which was echoed by the experimental observation that PIWIL1-overexpressing HCC cells attracted myeloid-derived suppressor cells (MDSCs) into the tumor microenvironment. MDSCs depletion reduced the proliferation and growth of PIWIL1-overexpressing HCC tumors. Complement C3, whose secretion was induced by PIWIL1 in HCC cells, mediates the interaction of HCC cells with MDSCs by activated p38 MAPK signaling in MDSCs, which in turn initiated expression of immunosuppressive cytokine IL10. Neutralizing IL10 secretion reduced the immunosuppressive activity of MDSCs in the microenvironment of PIWIL1-overexpressing HCC. Taken together, our study unraveled the critical role of PIWIL1 in initiating the interaction of cancer cell metabolism and immune cell response in HCC. Tumor cells-expressed PIWIL1 may be a potential target for the development of novel HCC treatment.